Recombinant DNA Totally Explained

Everything about Recombinant Dna Technology totally explained

Recombinant DNA is a form of artificial DNA that's engineered through the combination or insertion of one or more DNA strands, thereby combining DNA sequences that wouldn't normally occur together. In terms of genetic modification, recombinant DNA is produced through the addition of relevant DNA into an existing organismal genome, such as the plasmid of bacteria, to code for or alter different traits for a specific purpose, such as immunity. It differs from genetic recombination, in that it doesn't occur through processes within the cell or ribosome, but is exclusively engineered.
The Recombinant DNA technique was engineered by Stanley Norman Cohen and Herbert Boyer in 1973. They published their findings in a 1974 paper entitled "Construction of Biologically Functional Bacterial Plasmids in vitro", which described a technique to isolate and amplify genes or DNA segments and insert them into another cell with precision, creating a transgenic bacterium. Recombinant DNA technology was made possible by the discovery of restriction endonucleases by Werner Arber, Daniel Nathans, and Hamilton Smith, for which they received the 1978 Nobel Prize in Medicine.

Introduction

Because of the importance of DNA in the replication of new structures and characteristics of living organisms, it has widespread importance in recapitulating via viral or non-viral vectors, both desirable and undesirable characteristics of a species to achieve characteristic change or to counteract effects caused by genetic or imposed disorders that have effects upon cellular or organismal processes. Through the use of recombinant DNA, genes that are identified as important can be amplified and isolated for use in other species or applications, where there may be some form of genetic illness or discrepancy, and provides a different approach to complex biological problem solving.

Applications and methods

Cloning and relation to plasmids

The use of cloning is interrelated with Recombinant DNA in classical biology, as the term "clone" refers to a cell or organism derived from a parental organism, with modern biology referring to the term as a collection of cells derived from the same cell that remain identical. In addition, the Ti plasmid of the bacterium Agrobacterium tumefaciens can be used to integrate foreign DNA into the genomes of many plants. Other methods of introducing or creating recombinant DNA in eukaryotes include homologous recombination and transfection with modified viruses.

Chimeric plasmids

When recombinant DNA is then further altered or changed to host additional strands of DNA, the molecule formed is referred to as "chimeric" DNA molecule,
In the production of chimeric plasmids, the processes involved can be somewhat uncertain, which was used for its versatility, author Stephen S. Hall wrote that the supposed shortage is now known to be an assumption based on mistaken facts. He wrote:

To hear some tell it, there was never a supply problem with pig pancreases in the first place. "The whole thing was rubbish," insists Paul Haycook, research director at Squibb-Novo. "There was never a shortage of pig pancreases, and there never will be." Haycook blames the scare on a miscalculation by an official who had prepared projections for the Food and Drug Administration — a mistake based, ironically, on a mistake in an Eli Lilly training brochure which confused kilograms with pounds. Instead of projecting an insulin shortage by 1982, a revised FDA report predicted adequate insulin supplies through the year 2006. In any event, there's never likely to be a shortage caused by a scarcity of pancreases.

Scientists and entrepreneurs were very eager to prove they could devise another way to synthesize the hormone, in part, because of competition from other researchers and also because of the promise for the fame and fortune that its so-called "discovery" could bring them. Insulin was part of a wider vision to introduce biotechnology medicines, and was chosen specifically because it's a simple hormone and was therefore relatively easy to copy. However, the motive was never to improve the lives of people with diabetes, but to prove that the technology worked. Insulin was chosen as the ideal candidate because it's a relatively simple protein, it was so widely used that if researchers could prove that synthetic insulin was safe and effective, then the technology would be accepted as such, and it would open the flood gates for many other products to be made this way, along with millions of dollars.
   That was exactly what happened. One of the biggest breakthroughs in recombinant DNA technology happened in the manufacture of synthetic "human" insulin, which was the first medicine made via recombinant DNA technology ever to be approved by the FDA.
   The specific gene sequence, or oligonucleotide, that codes for insulin production in humans was introduced to a sample colony of E. coli. Only about 1 out of 10⁶ bacteria picks up the sequence. This isn't really a problem, however, because the life cycle is only about 30 minutes for E. coli. In a 24-hour period, there may be billions of E. coli that are coded with the DNA sequences needed to induce insulin production.
   However, a sampling of initial reaction showed that Humulin was greeted more as a technological rather than a medical breakthrough, and that this sentiment was building even before the drug reached pharmacies. As early as 1980, the British magazine New Scientist reported, "Other big chemical manufacturers predict that Eli Lilly's massive $40 million investment in two plants to make insulin - may be a classic example of backing a loser."
The Economist concluded: "The first bug-built drug for human use may turn out to be a commercial flop. But the way has now been cleared-and remarkably quickly, too - for biotechnologists with interesting new products to clear the regulatory hurdles and run away with the prizes."
Ultimately, widespread consumer adoption of synthetic "human" insulin didn't occur until the manufacturers removed highly-purified animal insulin from the market.

Further Information

Get more info on 'Recombinant Dna Technology'.

External Link Exchanges

Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:

<a href="http://recombinant_dna.totallyexplained.com">Recombinant DNA Totally Explained</a>

Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned.